Low protein expression of MET in ER-positive and HER2-positive breast cancer.
Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M.
Zagouri F, et al. Among authors: chrysikos d.
Anticancer Res. 2014 Mar;34(3):1227-31.
Anticancer Res. 2014.
PMID: 24596364